# Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial

> **NCT00500279** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 900 (estimated)

## Conditions studied

- Angioplasty, Transluminal, Percutaneous Coronary
- Coronary Restenosis

## Interventions

- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00500279
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2009-10
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2007-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00500279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00500279, "Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00500279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*